Several randomized trials show K2 supplementation reducing arterial stiffness and preserving bone mineral density in postmenopausal women [15]
These medications can provide meaningful benefits for weight management and metabolic health, but questions about long-term use, maintenance, and stopping treatment are common
Similarly, in another study, Zengin et al
rxlist.com (Ozempic) rxlist.com (Rybelsus) rxlist.com (Wegovy)
Lilly is also advancing oral GLP-1 agonists
It's important to acknowledge that these are common, with studies indicating that a significant percentage of users (reports range from 40% up to 85%) experience issues like nausea, vomiting, diarrhea, constipation, bloating, or heartburn, particularly when first starting the medication or increasing the dose